The gut microbiota is an important contributor to the worldwide prevalence of metabolic
syndrome (MS), which includes obesity and diabetes. The anti-MS effects exerted by …

Background and aims Despite strong mechanistic data, and promising results from in vitro
and animal studies, the ability of probiotic bacteria to improve blood pressure and serum …

Given the growing evidence that gut dysfunction, including changes in gut microbiota
composition, plays a critical role in the development of inflammation and metabolic …

Functional gastrointestinal symptoms are frequent, and may be driven by several pathogenic
mechanisms. Symptoms may persist in lactose intolerant (LI) patients (ie, subjects with …

Recent studies have demonstrated beneficial effects of specific probiotics on alleviating
obesity‐related disorders. Here we aimed to identify probiotics with potential antiobesity …

Objective: This study determined whether older adults who consumed a probiotic mixture
would have a greater proportion of circulating CD4+ lymphocytes, altered cytokine …

Thanks to recent scientific progress a relationship between the intestinal microbiota and
metabolic diseases could be established. A deeper understanding of underlying …

Background A multispecies probiotic has shown beneficial effects in irritable bowel
syndrome. In addition, certain other probiotics have demonstrated advantageous effects, but …

Probiotics are believed to have interaction with immune cells through sustained effects on
gene expression of different cytokines and transcription factors. The present randomized …

Objective: To assess the efficacy of probiotic therapies on body weight and BMI using a meta-
analysis of randomized, controlled trials. Methods: Twenty studies with 25 trials (1931 …